SEC Form 4 · accession 0001209191-15-029050

CORCEPT THERAPEUTICS INC · CORT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Mar 20, 2015

Accepted (ET)

Mar 24, 2015 · 9:50 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001088856

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F2	Mar 20, 2015	X	17,652	$2.77	A	909,426	I	By Family Partnership
Common Stock^F2	Mar 20, 2015	S	8,359	$5.85	D	901,067	I	By Family Partnership

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Warrant (Right to Buy)^F2	$2.77	Mar 20, 2015	X	17,652	D	Mar 25, 2008	Mar 24, 2015	Common Stock	17,652	0	I

F1On March 20, 2015, Mr. Wilson's Family Partnership exercised a warrant to purchase 17,652 shares of the Issuer's common stock for an exercise price of $2.77 per share. Mr. Wilson's family Partnership paid the exercise price on a cashless basis, resulting in the Issuer's withholding of 8,359 of such shares to pay the exercise and issuing to Mr. Wilson's Family Partnership the remaining 9,293 shares. In connection with such exercise, the Issuer also paid to Mr. Wilson's Family Partnership $4.11 in cash in lieu of a fractional share.
F2Reflects transactions and holdings of shares of common stock of the Issuer held of record by Mr. Wilson's Family Partnership.